Editorial: Understanding the Interplay Between the Tumor Immune Microenvironment and Genetic Alterations in Thoracic Malignancies

Editorial: Understanding the Interplay Between the Tumor Immune Microenvironment and Genetic Alterations in Thoracic Malignancies

Bibliographic Details
Main Authors:	Giulia Pasello, Jordi Remon, Emanuela Felley-Bosco
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-03-01
Series:	Frontiers in Oncology
Subjects:	tumor immune microenvironment genetic alteration lung cancer mesothelioma thymic epithelial tumor (TET)
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2022.871544/full

Similar Items

Clinical characteristics, prognostic factors, and long‐term outcomes associated with epithelial malignancies of the thymus: A 20‐year single‐institution experience
by: Ellery Altshuler, et al.
Published: (2023-03-01)

Immunocytometric analysis of patients with thymic epithelial tumors revealed that COVID-19 vaccine booster strongly enhanced the immune response
by: Gustavo Cernera, et al.
Published: (2023-08-01)

Current Treatment Approaches for Thymic Epithelial Tumors
by: Alfredo Tartarone, et al.
Published: (2023-05-01)

Nomogram based on TNM stage to predict the prognosis of thymic epithelial tumors (TETs) patients undergoing extended thymectomy
by: Yanzhi Li, et al.
Published: (2023-03-01)

Prognostic and immunological significance of metastasis-associated protein 3 in patients with thymic epithelial tumors
by: Jinping Li, et al.
Published: (2024-06-01)

Immunotherapy in thymic epithelial tumors: tissue predictive biomarkers for immune checkpoint inhibitors
by: Stefano Lucà, et al.
Published: (2024-05-01)

An Overview on Molecular Characterization of Thymic Tumors: Old and New Targets for Clinical Advances
by: Valentina Tateo, et al.
Published: (2021-04-01)

Chronic Inflammation, Oxidative Stress and Metabolic Plasticity: Three Players Driving the Pro-Tumorigenic Microenvironment in Malignant Mesothelioma
by: Irene Fiorilla, et al.
Published: (2023-08-01)

A novel risk classifier for predicting the overall survival of patients with thymic epithelial tumors based on the eighth edition of the TNM staging system: A population-based study
by: Yimeng Li, et al.
Published: (2022-12-01)

Surgical outcomes of 215 patients with thymic epithelial tumors: A single‐center experience
by: Wenxin Tian, et al.
Published: (2020-07-01)

Chinese expert consensus on the diagnosis and treatment of thymic epithelial tumors
by: Chunwei Xu, et al.
Published: (2023-04-01)

Tumor Microenvironment-Associated Immune-Related Genes for the Prognosis of Malignant Pleural Mesothelioma
by: Xiaoling Xu, et al.
Published: (2020-09-01)

Spatially resolved, high-dimensional transcriptomics sorts out the evolution of biphasic malignant pleural mesothelioma: new paradigms for immunotherapy
by: F Torricelli, et al.
Published: (2023-07-01)

Case Report: Paraneoplastic psoriasis in thymic carcinoma
by: Lucas Mix, et al.
Published: (2023-08-01)

Multimodal management and complete resection of invasive Type B3 thymoma with vascular reconstruction: a case report
by: Puiyee Sophia Chan, et al.
Published: (2025-01-01)

Pediatric cancer—pathology and microenvironment influence: a perspective into osteosarcoma and non-osteogenic mesenchymal malignant neoplasms
by: Consolato M. Sergi
Published: (2024-08-01)

Editorial: Surgical treatment of thymic epithelial tumor and myasthenia gravis
by: Piergiorgio Muriana
Published: (2025-01-01)

Thymic Epithelial Tumors: An Evolving Field
by: Elisabetta Kuhn, et al.
Published: (2023-01-01)

Brief Report: High Levels of CD47 Expression in Thymic Epithelial Tumors
by: Thomas Yang Sun, MD, MHS, et al.
Published: (2023-04-01)

Apatinib in patients with recurrent or metastatic thymic epithelial tumor: a single-arm, multicenter, open-label, phase II trial
by: Zhengbo Song, et al.
Published: (2022-05-01)

Peritumoral imaging features of thymic epithelial tumors for the prediction of transcapsular invasion: beyond intratumoral analysis
by: Jongmin Park, et al.
Published: (2023-01-01)

Epidemiology of thymomas and thymic carcinomas in the United States and Germany, 1999-2019
by: Tiemo Sven Gerber, et al.
Published: (2024-01-01)

Thymic Epithelial Tumors as a Model of Networking: Development of a Synergistic Strategy for Clinical and Translational Research Purposes
by: Enrico Melis, et al.
Published: (2020-07-01)

Autoimmune Disease in Patients With Advanced Thymic Epithelial Tumors
by: Surbhi Singhal, MD, et al.
Published: (2022-05-01)

MicroRNA Functions in Thymic Biology: Thymic Development and Involution
by: Minwen Xu, et al.
Published: (2018-09-01)

BAP1 Deficiency Inflames the Tumor Immune Microenvironment and Is a Candidate Biomarker for Immunotherapy Response in Malignant Pleural Mesothelioma
by: Duo Xu, MD, PhD, et al.
Published: (2024-05-01)

Artificial intelligence‐powered spatial analysis of tumor‐infiltrating lymphocytes as a biomarker in locally advanced unresectable thymic epithelial neoplasm: A single‐center, retrospective, longitudinal cohort study
by: Dong Hyun Kim, et al.
Published: (2023-10-01)

Heterogeneous RNA editing and influence of ADAR2 on mesothelioma chemoresistance and the tumor microenvironment
by: Ananya Hariharan, et al.
Published: (2022-12-01)

Postoperative clinical outcomes of patients with thymic epithelial tumors after over-3-year follow-up at a single-center
by: Peng Jiao, et al.
Published: (2023-02-01)

Detection of Epstein–Barr virus infection in thymic epithelial tumors by nested PCR and Epstein–Barr-encoded RNA ISH
by: Li Zhao, et al.
Published: (2023-06-01)

Small molecule multitarget antiangiogenic inhibitor treatments for advanced thymic epithelial tumors: A retrospective study
by: Wanji Shen, et al.
Published: (2024-01-01)

Searching for Novel Biomarkers in Thymic Epithelial Tumors: Immunohistochemical Evaluation of Hippo Pathway Components in a Cohort of Thymic Epithelial Tumors
by: Kostas Palamaris, et al.
Published: (2023-07-01)

Unraveling molecular networks in thymic epithelial tumors: deciphering the unique signatures
by: Xiao Zhang, et al.
Published: (2023-10-01)

Cine MR feature tracking analysis for diagnosing thymic epithelial tumors: a feasibility study
by: Koji Takumi, et al.
Published: (2023-05-01)

Multiparameter diagnostic model based on 18F-FDG PET and clinical characteristics can differentiate thymic epithelial tumors from thymic lymphomas
by: Guanyun Wang, et al.
Published: (2022-08-01)

Immunotherapy for epithelial tumors of the thymus
by: O. I. Kit, et al.
Published: (2023-09-01)

Identification of Tumor Antigens and Immune Subtypes of Malignant Mesothelioma for mRNA Vaccine Development
by: Shuhang Wang, et al.
Published: (2022-07-01)

How to Better Understand the Influence of Host Genetics on Developing an Effective Immune Response to Thoracic Cancers
by: Kiarash Behrouzfar, et al.
Published: (2021-06-01)

The Immune Microenvironment in Mesothelioma: Mechanisms of Resistance to Immunotherapy
by: Gerard J. Chu, et al.
Published: (2019-12-01)

Editorial: Focus on malignant pleural mesothelioma immunology and immunotherapy
by: Chiara Porta, et al.
Published: (2023-07-01)